AVALON PHARMA

Middle East Pharmaceutical Industries Company

4016StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

1-5

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operations
Operating Cash Flow	88.54M	33.08M	92.66M	68.57M	40.72M
Free Cash Flow	73.74M	21.91M	71.82M	58.99M	25.28M
Capital Expenditures	-14.79M	-11.17M	-20.83M	-9.58M	-15.43M
Investing & Financing
Investing Cash Flow	-34.38M	-20.04M	-30.83M	-20.20M	-24.80M
Financing Cash Flow	-50.23M	-5.50M	-70.51M	-43.61M	-12.82M
Dividends Paid	-46.98M	-15.00M	-36.00M	-36.35M	-37.20M
Operating Activities
Operating Cash Flow	88.54M	33.08M	92.66M	68.57M	40.72M
Net Income	97.01M	79.85M	65.83M	59.45M	66.28M
Change in Accounts Payable	16.67M	-1.03M	-9.91M	5.22M	6.53M
Change in Accounts Receivable	-40.82M	-57.66M	-5.17M	12.66M	-54.50M
Change in Inventory	-7.22M	-11.70M	12.45M	-27.38M	8.19M
Change in Other Net Operating Assets	-2.93M	-6.22M	12.95M	-0.03M	2.74M
Change in Working Capital	-34.29M	-76.60M	10.31M	-9.53M	-37.05M
Other Operating Activities	4.32M	10.57M	5.77M	7.91M	-0.88M
Provision & Write-off of Bad Debts	1.47M	3.54M	-1.51M	0.13M	—
Depreciation & Amortization	12.22M	9.80M	7.61M	6.84M	6.70M
Other Amortization	7.78M	6.04M	4.32M	3.78M	2.87M
Cash Interest Paid	3.22M	1.46M	4.33M	3.93M	—
Miscellaneous Cash Flow Adjustments	—	-18.49K	—	—	11.46K
Asset Writedown & Restructuring Costs	70.10K	—	453.76K	56.25K	—
Investing Activities
Investing Cash Flow	-34.38M	-20.04M	-30.83M	-20.20M	-24.80M
Capital Expenditures	-14.79M	-11.17M	-20.83M	-9.58M	-15.43M
Divestitures	—	—	—	—	—
Investment in Securities	—	0.77M	—	—	-0.17M
Sale (Purchase) of Intangibles	-19.62M	-9.78M	-10.14M	-11.03M	-9.25M
Sale of Property, Plant & Equipment	40.87K	142.83K	136.80K	406.19K	44.21K
Loss (Gain) From Sale of Assets	-40.87K	-120.77K	-126.03K	-77.16K	34.37K
Loss (Gain) on Sale of Investments	—	—	—	—	2.76M
Financing Activities
Financing Cash Flow	-50.23M	-5.50M	-70.51M	-43.61M	-12.82M
Common Dividends Paid	-46.98M	-15.00M	-36.00M	-36.35M	-37.20M
Long-Term Debt Issued	26.14M	—	—	—	83.52M
Short-Term Debt Issued	42.39M	87.19M	174.13M	121.94M	—
Total Debt Issued	68.53M	87.19M	174.13M	121.94M	83.52M
Long-Term Debt Repaid	-3.48M	-6.34M	-6.34M	-4.75M	-59.13M
Short-Term Debt Repaid	-65.09M	-77.38M	-192.99M	-119.25M	—
Total Debt Repaid	-68.56M	-83.72M	-199.33M	-124.00M	-59.13M
Net Debt Issued (Repaid)	-0.03M	3.48M	-25.20M	-2.06M	24.38M
Other Financing Activities	-3.22M	6.02M	-9.31M	-5.20M	—
Free Cash Flow & Returns
Free Cash Flow	73.74M	21.91M	71.82M	58.99M	25.28M
Free Cash Flow Growth	+236.6%	-69.5%	+21.8%	+133.3%	+121.5%
Free Cash Flow Margin	+16.0%	+5.6%	+21.2%	+19.5%	+8.8%
Free Cash Flow Per Share	3.69	1.10	3.59	2.95	1.26
Levered Free Cash Flow	23.27M	-5.47M	29.26M	22.98M	-6.24M
Unlevered Free Cash Flow	25.30M	-3.17M	32.86M	25.94M	-5.08M
Operating Cash Flow Growth	+167.7%	-64.3%	+35.1%	+68.4%	-8.3%
Net Cash Flow	3.93M	7.52M	-8.68M	4.76M	3.11M

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Annual (SAR)

1-5

	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022	2021Dec 31, 2021
Operations
Operating Cash Flow	88.54M	33.08M	92.66M	68.57M	40.72M
Free Cash Flow	73.74M	21.91M	71.82M	58.99M	25.28M
Capital Expenditures	-14.79M	-11.17M	-20.83M	-9.58M	-15.43M
Investing & Financing
Investing Cash Flow	-34.38M	-20.04M	-30.83M	-20.20M	-24.80M
Financing Cash Flow	-50.23M	-5.50M	-70.51M	-43.61M	-12.82M
Dividends Paid	-46.98M	-15.00M	-36.00M	-36.35M	-37.20M
Operating Activities
Operating Cash Flow	88.54M	33.08M	92.66M	68.57M	40.72M
Net Income	97.01M	79.85M	65.83M	59.45M	66.28M
Change in Accounts Payable	16.67M	-1.03M	-9.91M	5.22M	6.53M
Change in Accounts Receivable	-40.82M	-57.66M	-5.17M	12.66M	-54.50M
Change in Inventory	-7.22M	-11.70M	12.45M	-27.38M	8.19M
Change in Other Net Operating Assets	-2.93M	-6.22M	12.95M	-0.03M	2.74M
Change in Working Capital	-34.29M	-76.60M	10.31M	-9.53M	-37.05M
Other Operating Activities	4.32M	10.57M	5.77M	7.91M	-0.88M
Provision & Write-off of Bad Debts	1.47M	3.54M	-1.51M	0.13M	—
Depreciation & Amortization	12.22M	9.80M	7.61M	6.84M	6.70M
Other Amortization	7.78M	6.04M	4.32M	3.78M	2.87M
Cash Interest Paid	3.22M	1.46M	4.33M	3.93M	—
Miscellaneous Cash Flow Adjustments	—	-18.49K	—	—	11.46K
Asset Writedown & Restructuring Costs	70.10K	—	453.76K	56.25K	—
Investing Activities
Investing Cash Flow	-34.38M	-20.04M	-30.83M	-20.20M	-24.80M
Capital Expenditures	-14.79M	-11.17M	-20.83M	-9.58M	-15.43M
Divestitures	—	—	—	—	—
Investment in Securities	—	0.77M	—	—	-0.17M
Sale (Purchase) of Intangibles	-19.62M	-9.78M	-10.14M	-11.03M	-9.25M
Sale of Property, Plant & Equipment	40.87K	142.83K	136.80K	406.19K	44.21K
Loss (Gain) From Sale of Assets	-40.87K	-120.77K	-126.03K	-77.16K	34.37K
Loss (Gain) on Sale of Investments	—	—	—	—	2.76M
Financing Activities
Financing Cash Flow	-50.23M	-5.50M	-70.51M	-43.61M	-12.82M
Common Dividends Paid	-46.98M	-15.00M	-36.00M	-36.35M	-37.20M
Long-Term Debt Issued	26.14M	—	—	—	83.52M
Short-Term Debt Issued	42.39M	87.19M	174.13M	121.94M	—
Total Debt Issued	68.53M	87.19M	174.13M	121.94M	83.52M
Long-Term Debt Repaid	-3.48M	-6.34M	-6.34M	-4.75M	-59.13M
Short-Term Debt Repaid	-65.09M	-77.38M	-192.99M	-119.25M	—
Total Debt Repaid	-68.56M	-83.72M	-199.33M	-124.00M	-59.13M
Net Debt Issued (Repaid)	-0.03M	3.48M	-25.20M	-2.06M	24.38M
Other Financing Activities	-3.22M	6.02M	-9.31M	-5.20M	—
Free Cash Flow & Returns
Free Cash Flow	73.74M	21.91M	71.82M	58.99M	25.28M
Free Cash Flow Growth	+236.6%	-69.5%	+21.8%	+133.3%	+121.5%
Free Cash Flow Margin	+16.0%	+5.6%	+21.2%	+19.5%	+8.8%
Free Cash Flow Per Share	3.69	1.10	3.59	2.95	1.26
Levered Free Cash Flow	23.27M	-5.47M	29.26M	22.98M	-6.24M
Unlevered Free Cash Flow	25.30M	-3.17M	32.86M	25.94M	-5.08M
Operating Cash Flow Growth	+167.7%	-64.3%	+35.1%	+68.4%	-8.3%
Net Cash Flow	3.93M	7.52M	-8.68M	4.76M	3.11M